Get Real Time Here
| Open4.150 | Close4.040 |
| Vol / Avg.11.525K / 15.621K | Mkt Cap12.792M |
| Day Range3.920 - 4.293 | 52 Wk Range2.034 - 8.730 |
VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
| Open4.150 | Close4.040 |
| Vol / Avg.11.525K / 15.621K | Mkt Cap12.792M |
| Day Range3.920 - 4.293 | 52 Wk Range2.034 - 8.730 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.990 | -2.820 | -0.8300 | ||||
| REV | 100.000K | 135.000K | 35.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | 28.00 | 28.00 |
| 2023-05-12 | Cantor Fitzgerald | Louise Chen | Maintains | Overweight | Raises | 5.00 | 9.00 |
| 2023-05-12 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 28.00 |
| 2023-04-19 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | Buy | Maintains | - | 28.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VYNE | VYNE Therapeutics | -2.74% | 12.8M |
| CING | Cingulate | -4.14% | 12M |
| ITRM | Iterum Therapeutics | 15.24% | 10.4M |
| COCP | Cocrystal Pharma | 5.13% | 20.9M |
| ONTX | Onconova Therapeutics | 5.76% | 16M |
How do I buy VYNE Therapeutics (VYNE) stock?
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Who are VYNE Therapeutics's (VYNE) competitors?
Other companies in VYNE Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
What is the target price for VYNE Therapeutics (VYNE) stock?
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for VYNE Therapeutics (VYNE)?
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.
Does VYNE Therapeutics (VYNE) pay a dividend?
There is no dividend information for VYNE Therapeutics.
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is VYNE Therapeutics (VYNE) going to split?
There is no upcoming split for VYNE Therapeutics.
What sector and industry does VYNE Therapeutics (VYNE) operate in?
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
| Open4.150 | Close4.040 |
| Vol / Avg.11.525K / 15.621K | Mkt Cap12.792M |
| Day Range3.920 - 4.293 | 52 Wk Range2.034 - 8.730 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.990 | -2.820 | -0.8300 | ||||
| REV | 100.000K | 135.000K | 35.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | 28.00 | 28.00 |
| 2023-05-12 | Cantor Fitzgerald | Louise Chen | Maintains | Overweight | Raises | 5.00 | 9.00 |
| 2023-05-12 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 28.00 |
| 2023-04-19 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | Buy | Maintains | - | 28.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VYNE | VYNE Therapeutics | -2.74% | 12.8M |
| CING | Cingulate | -4.14% | 12M |
| ITRM | Iterum Therapeutics | 15.24% | 10.4M |
| COCP | Cocrystal Pharma | 5.13% | 20.9M |
| ONTX | Onconova Therapeutics | 5.76% | 16M |
How do I buy VYNE Therapeutics (VYNE) stock?
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Who are VYNE Therapeutics's (VYNE) competitors?
Other companies in VYNE Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
What is the target price for VYNE Therapeutics (VYNE) stock?
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for VYNE Therapeutics (VYNE)?
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.
Does VYNE Therapeutics (VYNE) pay a dividend?
There is no dividend information for VYNE Therapeutics.
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is VYNE Therapeutics (VYNE) going to split?
There is no upcoming split for VYNE Therapeutics.
What sector and industry does VYNE Therapeutics (VYNE) operate in?
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
| Open4.150 | Close4.040 |
| Vol / Avg.11.525K / 15.621K | Mkt Cap12.792M |
| Day Range3.920 - 4.293 | 52 Wk Range2.034 - 8.730 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.990 | -2.820 | -0.8300 | ||||
| REV | 100.000K | 135.000K | 35.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | 28.00 | 28.00 |
| 2023-05-12 | Cantor Fitzgerald | Louise Chen | Maintains | Overweight | Raises | 5.00 | 9.00 |
| 2023-05-12 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 28.00 |
| 2023-04-19 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | Buy | Maintains | - | 28.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VYNE | VYNE Therapeutics | -2.74% | 12.8M |
| CING | Cingulate | -4.14% | 12M |
| ITRM | Iterum Therapeutics | 15.24% | 10.4M |
| COCP | Cocrystal Pharma | 5.13% | 20.9M |
| ONTX | Onconova Therapeutics | 5.76% | 16M |
How do I buy VYNE Therapeutics (VYNE) stock?
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Who are VYNE Therapeutics's (VYNE) competitors?
Other companies in VYNE Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
What is the target price for VYNE Therapeutics (VYNE) stock?
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for VYNE Therapeutics (VYNE)?
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.
Does VYNE Therapeutics (VYNE) pay a dividend?
There is no dividend information for VYNE Therapeutics.
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is VYNE Therapeutics (VYNE) going to split?
There is no upcoming split for VYNE Therapeutics.
What sector and industry does VYNE Therapeutics (VYNE) operate in?
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
| Open4.150 | Close4.040 |
| Vol / Avg.11.525K / 15.621K | Mkt Cap12.792M |
| Day Range3.920 - 4.293 | 52 Wk Range2.034 - 8.730 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.990 | -2.820 | -0.8300 | ||||
| REV | 100.000K | 135.000K | 35.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | 28.00 | 28.00 |
| 2023-05-12 | Cantor Fitzgerald | Louise Chen | Maintains | Overweight | Raises | 5.00 | 9.00 |
| 2023-05-12 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 28.00 |
| 2023-04-19 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | Buy | Maintains | - | 28.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VYNE | VYNE Therapeutics | -2.74% | 12.8M |
| CING | Cingulate | -4.14% | 12M |
| ITRM | Iterum Therapeutics | 15.24% | 10.4M |
| COCP | Cocrystal Pharma | 5.13% | 20.9M |
| ONTX | Onconova Therapeutics | 5.76% | 16M |
How do I buy VYNE Therapeutics (VYNE) stock?
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Who are VYNE Therapeutics's (VYNE) competitors?
Other companies in VYNE Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
What is the target price for VYNE Therapeutics (VYNE) stock?
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for VYNE Therapeutics (VYNE)?
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.
Does VYNE Therapeutics (VYNE) pay a dividend?
There is no dividend information for VYNE Therapeutics.
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is VYNE Therapeutics (VYNE) going to split?
There is no upcoming split for VYNE Therapeutics.
What sector and industry does VYNE Therapeutics (VYNE) operate in?
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
| Open4.150 | Close4.040 |
| Vol / Avg.11.525K / 15.621K | Mkt Cap12.792M |
| Day Range3.920 - 4.293 | 52 Wk Range2.034 - 8.730 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.990 | -2.820 | -0.8300 | ||||
| REV | 100.000K | 135.000K | 35.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | 28.00 | 28.00 |
| 2023-05-12 | Cantor Fitzgerald | Louise Chen | Maintains | Overweight | Raises | 5.00 | 9.00 |
| 2023-05-12 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 28.00 |
| 2023-04-19 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | Buy | Maintains | - | 28.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VYNE | VYNE Therapeutics | -2.74% | 12.8M |
| CING | Cingulate | -4.14% | 12M |
| ITRM | Iterum Therapeutics | 15.24% | 10.4M |
| COCP | Cocrystal Pharma | 5.13% | 20.9M |
| ONTX | Onconova Therapeutics | 5.76% | 16M |
How do I buy VYNE Therapeutics (VYNE) stock?
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Who are VYNE Therapeutics's (VYNE) competitors?
Other companies in VYNE Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
What is the target price for VYNE Therapeutics (VYNE) stock?
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for VYNE Therapeutics (VYNE)?
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.
Does VYNE Therapeutics (VYNE) pay a dividend?
There is no dividend information for VYNE Therapeutics.
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is VYNE Therapeutics (VYNE) going to split?
There is no upcoming split for VYNE Therapeutics.
What sector and industry does VYNE Therapeutics (VYNE) operate in?
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
| Open4.150 | Close4.040 |
| Vol / Avg.11.525K / 15.621K | Mkt Cap12.792M |
| Day Range3.920 - 4.293 | 52 Wk Range2.034 - 8.730 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.990 | -2.820 | -0.8300 | ||||
| REV | 100.000K | 135.000K | 35.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | 28.00 | 28.00 |
| 2023-05-12 | Cantor Fitzgerald | Louise Chen | Maintains | Overweight | Raises | 5.00 | 9.00 |
| 2023-05-12 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 28.00 |
| 2023-04-19 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | Buy | Maintains | - | 28.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VYNE | VYNE Therapeutics | -2.74% | 12.8M |
| CING | Cingulate | -4.14% | 12M |
| ITRM | Iterum Therapeutics | 15.24% | 10.4M |
| COCP | Cocrystal Pharma | 5.13% | 20.9M |
| ONTX | Onconova Therapeutics | 5.76% | 16M |
How do I buy VYNE Therapeutics (VYNE) stock?
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Who are VYNE Therapeutics's (VYNE) competitors?
Other companies in VYNE Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
What is the target price for VYNE Therapeutics (VYNE) stock?
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for VYNE Therapeutics (VYNE)?
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.
Does VYNE Therapeutics (VYNE) pay a dividend?
There is no dividend information for VYNE Therapeutics.
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is VYNE Therapeutics (VYNE) going to split?
There is no upcoming split for VYNE Therapeutics.
What sector and industry does VYNE Therapeutics (VYNE) operate in?
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
| Open4.150 | Close4.040 |
| Vol / Avg.11.525K / 15.621K | Mkt Cap12.792M |
| Day Range3.920 - 4.293 | 52 Wk Range2.034 - 8.730 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.990 | -2.820 | -0.8300 | ||||
| REV | 100.000K | 135.000K | 35.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | 28.00 | 28.00 |
| 2023-05-12 | Cantor Fitzgerald | Louise Chen | Maintains | Overweight | Raises | 5.00 | 9.00 |
| 2023-05-12 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 28.00 |
| 2023-04-19 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | Buy | Maintains | - | 28.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VYNE | VYNE Therapeutics | -2.74% | 12.8M |
| CING | Cingulate | -4.14% | 12M |
| ITRM | Iterum Therapeutics | 15.24% | 10.4M |
| COCP | Cocrystal Pharma | 5.13% | 20.9M |
| ONTX | Onconova Therapeutics | 5.76% | 16M |
How do I buy VYNE Therapeutics (VYNE) stock?
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Who are VYNE Therapeutics's (VYNE) competitors?
Other companies in VYNE Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
What is the target price for VYNE Therapeutics (VYNE) stock?
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for VYNE Therapeutics (VYNE)?
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.
Does VYNE Therapeutics (VYNE) pay a dividend?
There is no dividend information for VYNE Therapeutics.
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is VYNE Therapeutics (VYNE) going to split?
There is no upcoming split for VYNE Therapeutics.
What sector and industry does VYNE Therapeutics (VYNE) operate in?
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
| Open4.150 | Close4.040 |
| Vol / Avg.11.525K / 15.621K | Mkt Cap12.792M |
| Day Range3.920 - 4.293 | 52 Wk Range2.034 - 8.730 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.990 | -2.820 | -0.8300 | ||||
| REV | 100.000K | 135.000K | 35.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | 28.00 | 28.00 |
| 2023-05-12 | Cantor Fitzgerald | Louise Chen | Maintains | Overweight | Raises | 5.00 | 9.00 |
| 2023-05-12 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 28.00 |
| 2023-04-19 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | Buy | Maintains | - | 28.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VYNE | VYNE Therapeutics | -2.74% | 12.8M |
| CING | Cingulate | -4.14% | 12M |
| ITRM | Iterum Therapeutics | 15.24% | 10.4M |
| COCP | Cocrystal Pharma | 5.13% | 20.9M |
| ONTX | Onconova Therapeutics | 5.76% | 16M |
How do I buy VYNE Therapeutics (VYNE) stock?
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Who are VYNE Therapeutics's (VYNE) competitors?
Other companies in VYNE Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
What is the target price for VYNE Therapeutics (VYNE) stock?
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for VYNE Therapeutics (VYNE)?
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.
Does VYNE Therapeutics (VYNE) pay a dividend?
There is no dividend information for VYNE Therapeutics.
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is VYNE Therapeutics (VYNE) going to split?
There is no upcoming split for VYNE Therapeutics.
What sector and industry does VYNE Therapeutics (VYNE) operate in?
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
| Open4.150 | Close4.040 |
| Vol / Avg.11.525K / 15.621K | Mkt Cap12.792M |
| Day Range3.920 - 4.293 | 52 Wk Range2.034 - 8.730 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.990 | -2.820 | -0.8300 | ||||
| REV | 100.000K | 135.000K | 35.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | 28.00 | 28.00 |
| 2023-05-12 | Cantor Fitzgerald | Louise Chen | Maintains | Overweight | Raises | 5.00 | 9.00 |
| 2023-05-12 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 28.00 |
| 2023-04-19 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | Buy | Maintains | - | 28.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VYNE | VYNE Therapeutics | -2.74% | 12.8M |
| CING | Cingulate | -4.14% | 12M |
| ITRM | Iterum Therapeutics | 15.24% | 10.4M |
| COCP | Cocrystal Pharma | 5.13% | 20.9M |
| ONTX | Onconova Therapeutics | 5.76% | 16M |
How do I buy VYNE Therapeutics (VYNE) stock?
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Who are VYNE Therapeutics's (VYNE) competitors?
Other companies in VYNE Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
What is the target price for VYNE Therapeutics (VYNE) stock?
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for VYNE Therapeutics (VYNE)?
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.
Does VYNE Therapeutics (VYNE) pay a dividend?
There is no dividend information for VYNE Therapeutics.
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is VYNE Therapeutics (VYNE) going to split?
There is no upcoming split for VYNE Therapeutics.
What sector and industry does VYNE Therapeutics (VYNE) operate in?
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.